Skip to main content
Erschienen in: Medical Oncology 12/2014

01.12.2014 | Original Paper

Two polymorphisms of USF1 gene (−202G>A and −844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case–control study in Chinese Han population

verfasst von: Xu Zhou, Hua-qiang Zhu, Chao-qun Ma, Hong-guang Li, Fang-feng Liu, Hong Chang, Jun Lu

Erschienen in: Medical Oncology | Ausgabe 12/2014

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular carcinoma (HCC) is a prototype of liver cancer, which is closely related to manifested metabolism of lip and glucose. Upstream transcription factor 1 (USF1) is an important transcription factor in human genome, and it regulates the expression of multiple genes associated with lipid and glucose metabolism. This study aims at investigating the correlation between seven common USF1 polymorphisms (i.e., −1994G>A, −202G>A, 7998A>G, −844C>T, 9042C>G, 9441T>C, and −2083G>A) and the risk of HCC. Elucidation of the interaction might be of vital importance to the diagnosis and prognosis of HCC. One hundred and fifty-five HCC patients and 160 healthy controls from a Chinese Han population were involved in this study. Tag single-nucleotide polymorphisms (SNPs) were identified with reference to CBI-dbSNP and HapMap databases. DNA was extracted from blood samples, and matrix-assisted laser desorption–ionization time-of-flight mass spectrometry (MALDI-TOF–MS) was conducted to determine the polymorphisms of USF1. Odds ratio (OR) and 95 % confidence interval were applied to evaluate the difference of genotype distribution. Seven SNPs were selected to be representatives. No significant difference was observed concerning −1994G>A, 7998A>G, 9042C>G, 9441T>C, and −2083G>A polymorphisms (all P > 0.05). A significantly elevated genotype frequency regarding −202G>A polymorphism was observed in HCC patients [AA vs. GG: OR 2.13 (1.13–4.01), P = 0.019; AA vs. GG+GA: OR 2.22 (1.32–3.75), P = 0.003; A allele vs. G allele: OR 1.46 (1.07–2.01), P = 0.018]. Subjects carrying mutant −844C>T genotypes also had a higher risk of HCC [CT vs. CC: OR 1.88 (1.17–3.04), P = 0.009; CT+TT vs. CC: OR 1.83 (1.17–2.86), P = 0.008; T allele vs. C allele: OR 1.49 (1.06–2.09), P = 0.020]. Further studies are recommended to validate our findings in different ethnicity and to clarify the functional relationship between USF1 polymorphisms and the susceptibility of HCC.
Literatur
1.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.PubMedCrossRef
3.
Zurück zum Zitat Feldstein AE. Novel insights into the pathophysiology of nonalcoholic fatty liver disease. Semin Liver Dis. 2010;30(4):391–401.PubMedCrossRef Feldstein AE. Novel insights into the pathophysiology of nonalcoholic fatty liver disease. Semin Liver Dis. 2010;30(4):391–401.PubMedCrossRef
4.
Zurück zum Zitat Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56(4):952–64.PubMedCrossRef Bechmann LP, Hannivoort RA, Gerken G, Hotamisligil GS, Trauner M, Canbay A. The interaction of hepatic lipid and glucose metabolism in liver diseases. J Hepatol. 2012;56(4):952–64.PubMedCrossRef
5.
Zurück zum Zitat Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51(5):1820–32.PubMedCrossRef Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51(5):1820–32.PubMedCrossRef
7.
Zurück zum Zitat Gaddikeri S, McNeeley MF, Wang CL, Bhargava P, Dighe MK, Yeh MM, et al. Hepatocellular carcinoma in the noncirrhotic liver. AJR Am J Roentgenol. 2014;203(1):11511.CrossRef Gaddikeri S, McNeeley MF, Wang CL, Bhargava P, Dighe MK, Yeh MM, et al. Hepatocellular carcinoma in the noncirrhotic liver. AJR Am J Roentgenol. 2014;203(1):11511.CrossRef
8.
Zurück zum Zitat Baron Y, Corre S, Mouchet N, Vaulont S, Prince S, Galibert MD. USF-1 is critical for maintaining genome integrity in response to UV-induced DNA photolesions. PLoS Genet. 2012;8(1):26.CrossRef Baron Y, Corre S, Mouchet N, Vaulont S, Prince S, Galibert MD. USF-1 is critical for maintaining genome integrity in response to UV-induced DNA photolesions. PLoS Genet. 2012;8(1):26.CrossRef
9.
Zurück zum Zitat Ribeiro A, Pastier D, Kardassis D, Chambaz J, Cardot P. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J Biol Chem. 1999;274(3):1216–25.PubMedCrossRef Ribeiro A, Pastier D, Kardassis D, Chambaz J, Cardot P. Cooperative binding of upstream stimulatory factor and hepatic nuclear factor 4 drives the transcription of the human apolipoprotein A-II gene. J Biol Chem. 1999;274(3):1216–25.PubMedCrossRef
10.
Zurück zum Zitat Holzapfel C, Baumert J, Grallert H, Muller AM, Thorand B, Khuseyinova N, et al. Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Eur J Endocrinol. 2008;159(4):407–16.PubMedCrossRef Holzapfel C, Baumert J, Grallert H, Muller AM, Thorand B, Khuseyinova N, et al. Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002. Eur J Endocrinol. 2008;159(4):407–16.PubMedCrossRef
11.
Zurück zum Zitat Lee SK, Kim HJ, Kim BJ, Jo YS, Park KS, Baik HW, et al. Body mass index is associated with USF1 haplotype in Korean premenopausal women. J Korean Med Sci. 2008;23(1):83–8.PubMedCentralPubMedCrossRef Lee SK, Kim HJ, Kim BJ, Jo YS, Park KS, Baik HW, et al. Body mass index is associated with USF1 haplotype in Korean premenopausal women. J Korean Med Sci. 2008;23(1):83–8.PubMedCentralPubMedCrossRef
12.
Zurück zum Zitat Naukkarinen J, Nilsson E, Koistinen HA, Soderlund S, Lyssenko V, Vaag A, et al. Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemias. Circ Cardiovasc Genet. 2009;2(5):522–9.PubMedCrossRef Naukkarinen J, Nilsson E, Koistinen HA, Soderlund S, Lyssenko V, Vaag A, et al. Functional variant disrupts insulin induction of USF1: mechanism for USF1-associated dyslipidemias. Circ Cardiovasc Genet. 2009;2(5):522–9.PubMedCrossRef
13.
Zurück zum Zitat Singmann P, Baumert J, Herder C, Meisinger C, Holzapfel C, Klopp N, et al. Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome. Obes Facts. 2009;2(4):235–42.PubMedCentralPubMedCrossRef Singmann P, Baumert J, Herder C, Meisinger C, Holzapfel C, Klopp N, et al. Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome. Obes Facts. 2009;2(4):235–42.PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Chanda D, Li T, Song KH, Kim YH, Sim J, Lee CH, et al. Hepatocyte growth factor family negatively regulates hepatic gluconeogenesis via induction of orphan nuclear receptor small heterodimer partner in primary hepatocytes. J Biol Chem. 2009;284(42):28510–21.PubMedCentralPubMedCrossRef Chanda D, Li T, Song KH, Kim YH, Sim J, Lee CH, et al. Hepatocyte growth factor family negatively regulates hepatic gluconeogenesis via induction of orphan nuclear receptor small heterodimer partner in primary hepatocytes. J Biol Chem. 2009;284(42):28510–21.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Chen Q, Seol DW, Carr B, Zarnegar R. Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines. Hepatology. 1997;26(1):59–66.PubMed Chen Q, Seol DW, Carr B, Zarnegar R. Co-expression and regulation of Met and Ron proto-oncogenes in human hepatocellular carcinoma tissues and cell lines. Hepatology. 1997;26(1):59–66.PubMed
16.
Zurück zum Zitat Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev. 2006;86(2):465–514.PubMedCrossRef Desvergne B, Michalik L, Wahli W. Transcriptional regulation of metabolism. Physiol Rev. 2006;86(2):465–514.PubMedCrossRef
17.
Zurück zum Zitat van Deursen D, van Leeuwen M, Vaulont S, Jansen H, Verhoeven AJ. Upstream Stimulatory Factors 1 and 2 activate the human hepatic lipase promoter via E-box dependent and independent mechanisms. Biochim Biophys Acta. 2009;4:229–37.CrossRef van Deursen D, van Leeuwen M, Vaulont S, Jansen H, Verhoeven AJ. Upstream Stimulatory Factors 1 and 2 activate the human hepatic lipase promoter via E-box dependent and independent mechanisms. Biochim Biophys Acta. 2009;4:229–37.CrossRef
18.
19.
Zurück zum Zitat Rearick D, Prakash A, McSweeny A, Shepard SS, Fedorova L, Fedorov A. Critical association of ncRNA with introns. Nucleic Acids Res. 2011;39(6):2357–66.PubMedCentralPubMedCrossRef Rearick D, Prakash A, McSweeny A, Shepard SS, Fedorova L, Fedorov A. Critical association of ncRNA with introns. Nucleic Acids Res. 2011;39(6):2357–66.PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Laurila PP, Naukkarinen J, Kristiansson K, Ripatti S, Kauttu T, Silander K, et al. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(2):346–52.PubMedCentralPubMedCrossRef Laurila PP, Naukkarinen J, Kristiansson K, Ripatti S, Kauttu T, Silander K, et al. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30(2):346–52.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Putt W, Palmen J, Nicaud V, Tregouet DA, Tahri-Daizadeh N, Flavell DM, et al. Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European atherosclerosis research study II. Hum Mol Genet. 2004;13(15):1587–97.PubMedCrossRef Putt W, Palmen J, Nicaud V, Tregouet DA, Tahri-Daizadeh N, Flavell DM, et al. Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European atherosclerosis research study II. Hum Mol Genet. 2004;13(15):1587–97.PubMedCrossRef
23.
Zurück zum Zitat Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? World J Gastroenterol. 2014;20(27):9072–89.PubMedCentralPubMed Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? World J Gastroenterol. 2014;20(27):9072–89.PubMedCentralPubMed
24.
Zurück zum Zitat Trauner M, Arrese M, Wagner M. Fatty liver and lipotoxicity. Biochim Biophys Acta. 2010;3:299–310.CrossRef Trauner M, Arrese M, Wagner M. Fatty liver and lipotoxicity. Biochim Biophys Acta. 2010;3:299–310.CrossRef
Metadaten
Titel
Two polymorphisms of USF1 gene (−202G>A and −844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case–control study in Chinese Han population
verfasst von
Xu Zhou
Hua-qiang Zhu
Chao-qun Ma
Hong-guang Li
Fang-feng Liu
Hong Chang
Jun Lu
Publikationsdatum
01.12.2014
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 12/2014
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-014-0301-4

Weitere Artikel der Ausgabe 12/2014

Medical Oncology 12/2014 Zur Ausgabe

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Alter verschlechtert Prognose bei Endometriumkarzinom

11.05.2024 Endometriumkarzinom Nachrichten

Ein höheres Alter bei der Diagnose eines Endometriumkarzinoms ist mit aggressiveren Tumorcharakteristika assoziiert, scheint aber auch unabhängig von bekannten Risikofaktoren die Prognose der Erkrankung zu verschlimmern.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.